Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alba A Brandes

Showing results (11-20 of 178) with videos related to

Pageof 18
Sort By:
Expert Review of Anticancer Therapy|April 12, 2017
Fertility preservation in women with CNS tumorsAlicia Tosoni, Damiano Balestrini, Alba A Brandes
Future Oncology (London, England)|September 12, 2015
Bevacizumab in recurrent glioblastoma: open issuesEnrico Franceschi, Marco Bartolotti, Alba A Brandes
Future Oncology (London, England)|October 26, 2013
Treatment of brain metastases from HER-2-positive breast cancer: current status and new conceptsMarco Bartolotti, Enrico Franceschi, Alba A Brandes
Expert Review of Anticancer Therapy|July 24, 2004
Current clinical management of gastrointestinal stromal tumorsAlicia Tosoni, Linda Nicolardi, Alba A Brandes
CNS Drugs|July 7, 2017
Pharmacotherapy of Glioblastoma: Established Treatments and Emerging ConceptsEnrico Franceschi, Santino Minichillo, Alba A Brandes
Critical Reviews in Oncology/Hematology|December 8, 2004
The pathogenesis and treatment of brain metastases: a comprehensive reviewAlicia Tosoni, Mario Ermani, Alba A Brandes
Expert Review of Anticancer Therapy|April 27, 2013
Second surgery for recurrent glioblastoma: advantages and pitfallsAlba A Brandes, Marco Bartolotti, Enrico Franceschi
Expert Review of Anticancer Therapy|November 6, 2003
Recommendations for the management of malignant gliomas in the elderlyUmberto Basso, Silvio Monfardini, Alba A Brandes
Oncology and Therapy|July 24, 2020
The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteriaAndrea Lanese, Enrico Franceschi, Alba A Brandes
Expert Review of Anticancer Therapy|October 18, 2002
Controversies in the therapy of low-grade glioma: when and how to treatAlba A Brandes, Francesca Vastola, Umberto Basso
Pageof 18

Showing results (11-20 of 178) with videos related to

Sort By:
Pageof 18
Expert Review of Anticancer Therapy|April 12, 2017
Fertility preservation in women with CNS tumorsAlicia Tosoni, Damiano Balestrini, Alba A Brandes
Future Oncology (London, England)|September 12, 2015
Bevacizumab in recurrent glioblastoma: open issuesEnrico Franceschi, Marco Bartolotti, Alba A Brandes
Future Oncology (London, England)|October 26, 2013
Treatment of brain metastases from HER-2-positive breast cancer: current status and new conceptsMarco Bartolotti, Enrico Franceschi, Alba A Brandes
Expert Review of Anticancer Therapy|July 24, 2004
Current clinical management of gastrointestinal stromal tumorsAlicia Tosoni, Linda Nicolardi, Alba A Brandes
CNS Drugs|July 7, 2017
Pharmacotherapy of Glioblastoma: Established Treatments and Emerging ConceptsEnrico Franceschi, Santino Minichillo, Alba A Brandes
Critical Reviews in Oncology/Hematology|December 8, 2004
The pathogenesis and treatment of brain metastases: a comprehensive reviewAlicia Tosoni, Mario Ermani, Alba A Brandes
Expert Review of Anticancer Therapy|April 27, 2013
Second surgery for recurrent glioblastoma: advantages and pitfallsAlba A Brandes, Marco Bartolotti, Enrico Franceschi
Expert Review of Anticancer Therapy|November 6, 2003
Recommendations for the management of malignant gliomas in the elderlyUmberto Basso, Silvio Monfardini, Alba A Brandes
Oncology and Therapy|July 24, 2020
The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteriaAndrea Lanese, Enrico Franceschi, Alba A Brandes
Expert Review of Anticancer Therapy|October 18, 2002
Controversies in the therapy of low-grade glioma: when and how to treatAlba A Brandes, Francesca Vastola, Umberto Basso
Pageof 18